For eligible cell and gene therapy executives and investors. 15 November, The Shard, London.
Privacy choices
Essential runs the site. Unless you reject or keep Essential only, we count visits anonymously, without cookies. Recommended adds fuller analytics and recordings of site use to help us improve it, and enables chat with our real-life team and their AI chat assistants to help with any of your queries. You can change this at any time. Privacy and cookies